01
marca

 personal finance programs

Obama administration officials today announced a proposed $1.25 billion settlement to resolve racial discrimination claims by potentially tens of thousands of black farmers who were denied equal access to U.S. Agriculture Department loan programs.

The settlement addresses claims from black farmers who were excluded from participation in an earlier settlement with the government over USDA loan discrimination. Late-filed or incomplete paperwork meant thousands of farmers were left out.

The settlement announced today by Associate Attorney General Thomas Perrelli of the Justice Department and Secretary Thomas Vilsack of the Agriculture Department sets up a nonjudicial claims process through which individual farmers may demonstrate entitlement to damages awards and debt relief.

Perrelli called the settlement a “great landmark” that highlights his department’s commitment to civil rights. The discrimination was part of a “troubling” and “sordid” chapter at USDA, Vilsack said, and the Agriculture Department is looking to move forward to reduce complaints and modernize.

The settlement is contingent on congressional authorization, for which there is a March 31 deadline. A range of attorney fees—between about 4% and 7%, or $49 million to $89 million—is part of the settlement agreement, according to Perrelli. He called it a “relatively complicated” set of attorney fee provisions that address prior and future work. Judge Paul Friedman of the U.S. District Court for the District of Columbia, who has presided over the case, will have the final say on fees.

“Bringing this litigation to a close has been a priority for this Administration. With the settlement announced today, USDA and the African American farmers who brought this litigation can move on to focus on their future,” Attorney General Eric Holder Jr. said in a statement. “The plaintiffs can move forward and have their claims heard—with the federal government standing not as an adversary, but as a partner.”

Whole Foods Markets (WFMI) CEO John Mackey (pictured), unsurprisingly, is passionate about health. Leading the country's largest and most respected chain of natural groceries, he's often credited with bringing natural-foods stores to the mainstream. On a personal note, he has been a vegan for many years and has adopted a diet free of vegetable oils, sugars and almost any processed food. So when he launched a plan to give his employees discounts on health insurance if they maintained lower readings for blood pressure, cholesterol and body mass index, it should have barely made a blip in the annals of corporate wellness.

But Mackey's plan is drawing fire, in part because his wellness program, some charge, comes off as heavy-handed and focuses too much on what have been called “arbitrary” measures such as body mass index (BMI) — or essentially how fat we are. Others say the plan is taking criticism simply because of Mackey's outspokenness on health.

Most famously, he wrote an op-ed blasting the U.S. health care reform effort in The Wall Street Journal in August, 2009. In the piece, he called the reform bill “Obamacare” and “a massive new health care entitlement.” He suggested the government instead adopt a series of reforms designed to encourage companies to provide health care for their employees. Among them, he suggested tax-free status for all health care premiums, fewer coverage mandates and other changes.

Finally, he said government should make it easy for taxpayers to give money to charities to cover the uninsured. In conclusion, he wrote, “We are all responsible for our own lives and our own health. We should … use our freedom to make wise lifestyle choices that will protect our health.”

Employee Biometric Screenings

Mackey's new health insurance discounts — in his words “empowering and fun for employees who enjoy a challenge” — fit right in with his corporation-knows-best attitude. Those who want to take part can undergo biometric screening, which will determine what discount level they'll receive: Bronze, silver, gold or platinum. The maximum discount is 30%, and to qualify, employees must have a BMI of less than 24, cholesterol levels below 150 mg/dL and blood pressure of 110/70.

Those with a BMI over 30 would not qualify for the program at all. They would, of course, still be eligible for health insurance — just without an extra discount. The bronze level provides a 22% discount.

For any other CEO, these initiatives might have passed with little notice. Corporate wellness programs have become a given, with discounts on gym memberships and cheery marketing for healthy options in corporate cafeterias. Many company executives have made news with far more shocking employee health tactics, including weight-loss contests and quit-smoking support groups. A few have even refused employment to smokers and told existing employees to quit, or lose a job.

The Peacock CEO

By comparison, Mackey's moves hardly seem controversial. But this is Mackey, the rare peacock of a CEO. His outsize personality, so politically at odds with the majority of his customer base, doesn't just invite, but begs, response from liberal media outlets. So they seize on the news, spinning it into the controversy they expect from a man like Mackey. The Village Voice headline proclaims, “Whole Foods' John Mackey Finds a New Way to Antagonize Customers,” pointing out, “the National Association to Advance Fat Acceptance is not amused.”

At The Big Money, Dan Mitchell doesn't like the plan, calling the choice of BMI, blood pressure and cholesterol “arbitrary,” a bad way to measure overall health. He worries that “the inevitable conclusion from this: Whole Foods theoretically would give discounts to near-death anorexics, who would be judged 'healthier' than their larger counterparts.” He suggests Whole Foods provide a discount for healthy grocery items for all employees.

Judging from the details of the Whole Foods wellness program, Mackey, it seems, knows best which lifestyle choices are good for health. What he doesn't know so well, is how to communicate his wisdom to the sort of person who's likely to work for, or shop at, Whole Foods. He once famously criticized his own company's stores for selling “junk food,” for instance, getting a lot of flak from his stakeholders.

Boycotts and “Buycotts”

Mackey was also surprised by the firestorm kicked up by his op-ed criticizing the reform effort in the Journal. In reaction, groups of liberal and conservative Whole Foods shoppers staged simultaneous boycotts and “buycotts,” which had no discernible effect on Whole Foods sales, but had a quite far-reaching effect on the talking points of conservative pundits in the first few weeks of September 2009.

Michelle Malkin, for instance, encouraged her readers to “buy a few Whole Foods items” in order to stand up for Mackey's opposition for health care, “I think it's worth it.” Malkin isn't, however, the prototypical Whole Foods shopper, nor, for that matter, the prototypical employee.

This is a company that encourages the sort of autonomous, bottom-up store organization that would seem more at home in the Socialist Party than the Republican Party. Lower-level employees help select and evaluate their bosses, even having a say on the store's product mix. Mackey pays himself a dollar a year. No executive makes more than 19 times the average employee's wage of $16.50 an hour.

“Right-Wing Hippie”

On the other hand? Mackey is as far from the left as you can get. He believes that corporations — and not governments or nonprofits — are the best way to provide for the well-being of the people. Companies should make enormous profits to put them to use for the betterment of humanity, he believes.

Says Nick Paumgarten in this New Yorker profile of Mackey: “The right-wing hippie is a rare bird.” And this right-wing hippie is simply roosting in his favorite nest with his latest plan. It's not even the first time he's offered inducements for his employees to be more healthy. His company conducts a three-month-long contest each year with prizes for the team whose members exercise and use mass transit the most.

Paumgarten concludes: “It sometimes sounds as if he believed that, if every company had him at the helm, there would be no need for unions or health care reform, and that therefore every company should have someone like him, and that therefore there should be no unions or health care reform.”

Saving Employees From Themselves?

That, in essence, seems to be the inspiration behind the latest Whole Foods wellness plan. It's myopic, paternalistic and with a generosity of intention that belies its know-it-all spirit.

Mackey thinks he's saving his employees from themselves. In reality, he's just giving a little bonus to those who are already most like himself — making employees in his own image a little tiny bit richer. It's not quite a God complex. But it's a nice, slim, start.

MABUHAY ALLIANCE HOST THE 6TH ANNUAL ECONOMIC DEVELOPMENT CONFERENCE by mabuhayalliance

http://removeripoffreports.net

28
lutego

 personal finance programs

Obama administration officials today announced a proposed $1.25 billion settlement to resolve racial discrimination claims by potentially tens of thousands of black farmers who were denied equal access to U.S. Agriculture Department loan programs.

The settlement addresses claims from black farmers who were excluded from participation in an earlier settlement with the government over USDA loan discrimination. Late-filed or incomplete paperwork meant thousands of farmers were left out.

The settlement announced today by Associate Attorney General Thomas Perrelli of the Justice Department and Secretary Thomas Vilsack of the Agriculture Department sets up a nonjudicial claims process through which individual farmers may demonstrate entitlement to damages awards and debt relief.

Perrelli called the settlement a “great landmark” that highlights his department’s commitment to civil rights. The discrimination was part of a “troubling” and “sordid” chapter at USDA, Vilsack said, and the Agriculture Department is looking to move forward to reduce complaints and modernize.

The settlement is contingent on congressional authorization, for which there is a March 31 deadline. A range of attorney fees—between about 4% and 7%, or $49 million to $89 million—is part of the settlement agreement, according to Perrelli. He called it a “relatively complicated” set of attorney fee provisions that address prior and future work. Judge Paul Friedman of the U.S. District Court for the District of Columbia, who has presided over the case, will have the final say on fees.

“Bringing this litigation to a close has been a priority for this Administration. With the settlement announced today, USDA and the African American farmers who brought this litigation can move on to focus on their future,” Attorney General Eric Holder Jr. said in a statement. “The plaintiffs can move forward and have their claims heard—with the federal government standing not as an adversary, but as a partner.”

Tea partiers will be the first to tell you that they don’t intend to
start a third party. They’re angry with Washington and with the
behavior of both parties, but the way toward the nation’s salvation is
to hold current leaders more accountable, not sending new ones to fill
the ranks of Congress. “We just don’t have enough time to do that,”
says Joyce Smith, a retiree from Ellijay, Ga.

Since the movement’s first-ever convention started in Nashville on
Thursday, the pursuit for reporters has simply been to figure out the
force of the movement and how formidable its voice will be in November.
Partiers are uniformly against public spending and expansion of
government, but it’s harder to figure out what exactly they’re for.
Campaigning on “throwing the bums out” might help win an election, but
it’s not a governing strategy. And until now, one of the movement’s
biggest snags has been its inability to articulate concrete changes it
would make to Washington and the federal government.

Until I met a man named Fred Everett, a tea-party patriot from Marietta, Ga. Cognizant of the movement’s lack of a concrete platform, he wrote one. He brought 500 copies to distribute to delegates as a proposed vision for the movement. It’s broken into two parts: fiscal reform and election reform—social programs aren’t included—and the idea is to get candidates to sign it as a pledge before they get tea-party support.

Under fiscal reform, Everett proposes curtailing all earmarks (“regardless of the importance of the legislation”) and balancing the budget by, as he says, sunsetting each and every federal program and “matching federal expenditures with federal revenues.” No exception, although one tiny caveat: no raising taxes. And on that note, he’d like to restructure the tax code to sharply reduce personal and corporate tax rates without shifting the income-tax burden from one income bracket to another. The result, he says, will “grow our national economic pie, create jobs, and increase federal tax revenues.”

Shifting to election reform, Everett thinks it’s unfair that incumbents have the upper hand to finance campaigns with taxpayer money when events coincide with their public duties. He thinks challengers should also get a weekly, federally funded town-hall meeting during the two months before each election. Once elected, lawmakers should be subject to term limits: eight years in the House and 12 years in the Senate. (Some tea partiers tell me the numbers should be higher, others say lower.) And last, to end gerrymandering, all House districts should be redrawn by an independent commission based on “democratic principles.”

Even though Everett’s contract offers some reasoned ideas, it’s a valid question whether candidates would sign on to something still so broad. But if they want tea-party support, they might have to. At yesterday’s press conference, convention organizer Judson Phillips laid down the gauntlet: “The tea party doesn’t endorse candidates; candidates endorse the tea party.”

MABUHAY ALLIANCE HOST THE 6TH ANNUAL ECONOMIC DEVELOPMENT CONFERENCE by mabuhayalliance

http://removeripoffreports.net

25
lutego

 web site promotion internet marketing

Pharmaceutical companies have begun creating a presence on Facebook characterized by control and caution. Why? Despite unclear regulations in the U.S. governing their presence online, they may still be penalized for marketing materials on the Internet. The result is, in terms of their Facebook marketing content, a mixed bag of sometimes disingenuous Pages and Groups, fluffy applications and tightly-controlled discussions.

In November of 2009 the U.S. Food and Drug Administration (FDA) hosted a hearing to examine this very issue: how to regulate drug companies’ marketing online — including social networks, blogs, podcasts, Wikipedia, etc. More than 800 parties tried to register to speak at the two-day hearing that included 69 speakers and 77 scheduled presentations; most attendees were either pharmaceutical or marketing reps, and the rest were a tiny fraction of consumers, non-profits and consumer advocacy groups.

According to the FDA, which regulates the promotion or advertising of pharmaceuticals in that country: “The continually evolving nature of the Internet, including Web 2.0 and social media tools… have raised questions and concerns over how to  apply existing regulations to promotion in these newer media.”

Currently there are no laws governing what pharmaceutical companies may or may not do online — aside from the general expectation that they disclose risk information alongside drug benefits. The last time the FDA broached the subject was 1996 and has since been based on guidelines for print marketing: where both benefits and risks of drugs must be presented side-by-side.

“The worry is the drug companies will find a way via the much more malleable and fluid environment of the Internet to promote their product in one-sided ways — and that’s not good,” said Steven Findlay, a senior health policy analyst with the Consumers Union who spoke at the FDA hearing. Facebook Pages for or by drug companies ought to include benefits and risks of drugs, he said, and be regulated by the FDA.

Several drug companies we saw on Facebook tried to mediate the info shared on their pages by closing their Walls, disallowing comments/likes and keeping consumers’ comments to a minimum by wielding tight control over Discussions.

The Facebook pages of Nexium (marketed to relieve heartburn caused by acid reflux disease) and Claritin Eye (eye drops for allergies) both closed off their Wall post to comments and likes. Both pages include information available on their product web sites.

“If they have a Wall, they can’t control what’s on it. If people complain about Nexium, then they’d either have to try to censor it, which would be potentially a problem, or they’d have to spend time responding to it,” said Diana Zuckerman, President of the National Research Center for Women and Families. “I would say to anyone who wants information about a medical product: Facebook is not the place to get it.”

Zuckerman testified at the FDA’s November hearing and said companies creating Facebook pages are likely to present information in such a way as to highlight the benefits without prominently pointing to the risks. Charging companies a fee payable to the FDA to monitor these sites would be the ideal way to ensure this doesn’t happen, she told us.

Claritin’s page has 6,600 fans and no place for comments, whereas Nexium has 508 fans and controls discussions by employing an app users have to allow access to before posting comments or questions. Nexium’s Facebook admin closely monitors these discussions, posting answers to questions or referring people to more information on Nexium’s web site.

Additional information on the pages include tabs for frequently asked questions, product information and risks, product savings programs, community guidelines for Facebook users (e.g., no obscenity or defamatory language) and tips.

Prevacid 24HR is another heartburn medication that had 8,000 fans on Facebook but took a radically different approach to its presence there than Nexium. Comments and likes are allowed on Prevacid’s Wall, although there were no active Discussions, and they even offered a coupon for discounts on their products.

There’s no penalty for misrepresenting information about a drug on Facebook, explained Zuckerman, although there is such a fine for similar misrepresentations in traditional media. What’s happened online is that pharma companies will present risk information, but it may not be where a user is likely to look, she told us.

“I think that, at the very least, these companies should have all of the same risk information that they’re required by law to include in television ads and magazine ads,” she says, noting that the unlimited space on the Internet would make this easier for the drug companies to accomplish.

Another tactic pharmaceutical companies are employing on Facebook: customized apps. Claritin’s page employed one, albeit the app was not closely related to the product. Claritin Eye Makeover allows users to upload photos of themselves to change and edit their eye color. Johnson & Johnson’s Acuminder, with 511 fans, is an app that reminds users when to change or purchase contact lenses, as well as remind them of their next eye exam.

Some companies also offer a Page or Group around a cause related to a drug. This is an especially gray area. Some examples we looked at clearly disclosed their sponsor relationship while others didn’t — either way, it appears that companies can be liable in some circumstances.

A Page with almost 109,000 members called Take A Step Against Cervical Cancer has ostensibly organized around preventing cancer — doing so by vaccinating young women with the HPV vaccine Gardasil, made by Merck. The Wall is practically non-existent, although there is information about side effects and links to Gardasil’s web sites on the page. There’s also an interactive fact book and quiz, and an app that allows users to make their own symbol against cervical cancer to post to their Walls.

Although rallying more than 100,000 people around a cause like cervical cancer and hiding the connection to a pharmaceutical company on the Info tab is not entirely a deception, but it’s also not transparent. Some similar Pages take this a step further.

Epilepsy Advocate, with 4,300 fans describes its Page as, “a community of people living well with epilepsy, their family members, and their caregivers. Epilepsy Advocates are people just like you who have shown the courage to share their stories and provide support to others.” Nowhere on the page, however, does it note that Epilepsy Advocate is a program sponsored by the pharmaceutical company UCB, which makes drugs for the treatment epilepsy. Although there are no strict laws governing pharma on social media, is it legal to promote an organization sponsored by a drug company without saying so?

It’s a slippery slope.

In UCB’s case, the Page itself is not currently illegal; however, the company is also responsible for the content. If a “user reported an adverse reaction to its treatment there, UCB would need to report it to the FDA,” according to an analysis by Adweek from December. “What’s more, pharma companies can be held liable by regulators for people discussing off-label use of their products on their sites.”

ADHD Moms, a Page for mothers of children with Attention Deficit Hyperactivity Disorder, is similar to the epilepsy page, but discloses on the Info tab that its page of 9,500 fans is sponsored by McNeil Pediatrics, a self-described leader of ADHS treatment with its Concerta drug. Disclosure about the Page’s sponsor is a good thing, but the implicit promotion of pharmaceuticals via an advocacy group walks a fine line.

It’s a complicated issue, said Findlay of the Consumers Union, because pharmaceutical companies have previously walked this fine line between providing useful information and hiding their sponsorship of it. Pharma companies are legally required to disclose such information in advertisements offline and, after years’ worth of reprimands from the FDA for not doing so, they’ve gotten the message, Findlay said. The way this message translates to the online world has yet to be seen.

Findlay tells us that a draft of regulations or guidelines for online marketing could come this year with a final ruling within two years. These regulations will most likely clarify the full disclosure of risks/benefits issue, he said.

“One should never make the mistake of underestimating the capacity, the resources and the willingness of companies to really aggressively marketing their products and to walk a thin line obeying the regulations,” he says. “They’ll go right up to the point where they don’t want to cross into illegality — but they come close.”

Pharmaceutical companies have begun creating a presence on Facebook characterized by control and caution. Why? Despite unclear regulations in the U.S. governing their presence online, they may still be penalized for marketing materials on the Internet. The result is, in terms of their Facebook marketing content, a mixed bag of sometimes disingenuous Pages and Groups, fluffy applications and tightly-controlled discussions.

In November of 2009 the U.S. Food and Drug Administration (FDA) hosted a hearing to examine this very issue: how to regulate drug companies’ marketing online — including social networks, blogs, podcasts, Wikipedia, etc. More than 800 parties tried to register to speak at the two-day hearing that included 69 speakers and 77 scheduled presentations; most attendees were either pharmaceutical or marketing reps, and the rest were a tiny fraction of consumers, non-profits and consumer advocacy groups.

According to the FDA, which regulates the promotion or advertising of pharmaceuticals in that country: “The continually evolving nature of the Internet, including Web 2.0 and social media tools… have raised questions and concerns over how to  apply existing regulations to promotion in these newer media.”

Currently there are no laws governing what pharmaceutical companies may or may not do online — aside from the general expectation that they disclose risk information alongside drug benefits. The last time the FDA broached the subject was 1996 and has since been based on guidelines for print marketing: where both benefits and risks of drugs must be presented side-by-side.

“The worry is the drug companies will find a way via the much more malleable and fluid environment of the Internet to promote their product in one-sided ways — and that’s not good,” said Steven Findlay, a senior health policy analyst with the Consumers Union who spoke at the FDA hearing. Facebook Pages for or by drug companies ought to include benefits and risks of drugs, he said, and be regulated by the FDA.

Several drug companies we saw on Facebook tried to mediate the info shared on their pages by closing their Walls, disallowing comments/likes and keeping consumers’ comments to a minimum by wielding tight control over Discussions.

The Facebook pages of Nexium (marketed to relieve heartburn caused by acid reflux disease) and Claritin Eye (eye drops for allergies) both closed off their Wall post to comments and likes. Both pages include information available on their product web sites.

“If they have a Wall, they can’t control what’s on it. If people complain about Nexium, then they’d either have to try to censor it, which would be potentially a problem, or they’d have to spend time responding to it,” said Diana Zuckerman, President of the National Research Center for Women and Families. “I would say to anyone who wants information about a medical product: Facebook is not the place to get it.”

Zuckerman testified at the FDA’s November hearing and said companies creating Facebook pages are likely to present information in such a way as to highlight the benefits without prominently pointing to the risks. Charging companies a fee payable to the FDA to monitor these sites would be the ideal way to ensure this doesn’t happen, she told us.

Claritin’s page has 6,600 fans and no place for comments, whereas Nexium has 508 fans and controls discussions by employing an app users have to allow access to before posting comments or questions. Nexium’s Facebook admin closely monitors these discussions, posting answers to questions or referring people to more information on Nexium’s web site.

Additional information on the pages include tabs for frequently asked questions, product information and risks, product savings programs, community guidelines for Facebook users (e.g., no obscenity or defamatory language) and tips.

Prevacid 24HR is another heartburn medication that had 8,000 fans on Facebook but took a radically different approach to its presence there than Nexium. Comments and likes are allowed on Prevacid’s Wall, although there were no active Discussions, and they even offered a coupon for discounts on their products.

There’s no penalty for misrepresenting information about a drug on Facebook, explained Zuckerman, although there is such a fine for similar misrepresentations in traditional media. What’s happened online is that pharma companies will present risk information, but it may not be where a user is likely to look, she told us.

“I think that, at the very least, these companies should have all of the same risk information that they’re required by law to include in television ads and magazine ads,” she says, noting that the unlimited space on the Internet would make this easier for the drug companies to accomplish.

Another tactic pharmaceutical companies are employing on Facebook: customized apps. Claritin’s page employed one, albeit the app was not closely related to the product. Claritin Eye Makeover allows users to upload photos of themselves to change and edit their eye color. Johnson & Johnson’s Acuminder, with 511 fans, is an app that reminds users when to change or purchase contact lenses, as well as remind them of their next eye exam.

Some companies also offer a Page or Group around a cause related to a drug. This is an especially gray area. Some examples we looked at clearly disclosed their sponsor relationship while others didn’t — either way, it appears that companies can be liable in some circumstances.

A Page with almost 109,000 members called Take A Step Against Cervical Cancer has ostensibly organized around preventing cancer — doing so by vaccinating young women with the HPV vaccine Gardasil, made by Merck. The Wall is practically non-existent, although there is information about side effects and links to Gardasil’s web sites on the page. There’s also an interactive fact book and quiz, and an app that allows users to make their own symbol against cervical cancer to post to their Walls.

Although rallying more than 100,000 people around a cause like cervical cancer and hiding the connection to a pharmaceutical company on the Info tab is not entirely a deception, but it’s also not transparent. Some similar Pages take this a step further.

Epilepsy Advocate, with 4,300 fans describes its Page as, “a community of people living well with epilepsy, their family members, and their caregivers. Epilepsy Advocates are people just like you who have shown the courage to share their stories and provide support to others.” Nowhere on the page, however, does it note that Epilepsy Advocate is a program sponsored by the pharmaceutical company UCB, which makes drugs for the treatment epilepsy. Although there are no strict laws governing pharma on social media, is it legal to promote an organization sponsored by a drug company without saying so?

It’s a slippery slope.

In UCB’s case, the Page itself is not currently illegal; however, the company is also responsible for the content. If a “user reported an adverse reaction to its treatment there, UCB would need to report it to the FDA,” according to an analysis by Adweek from December. “What’s more, pharma companies can be held liable by regulators for people discussing off-label use of their products on their sites.”

ADHD Moms, a Page for mothers of children with Attention Deficit Hyperactivity Disorder, is similar to the epilepsy page, but discloses on the Info tab that its page of 9,500 fans is sponsored by McNeil Pediatrics, a self-described leader of ADHS treatment with its Concerta drug. Disclosure about the Page’s sponsor is a good thing, but the implicit promotion of pharmaceuticals via an advocacy group walks a fine line.

It’s a complicated issue, said Findlay of the Consumers Union, because pharmaceutical companies have previously walked this fine line between providing useful information and hiding their sponsorship of it. Pharma companies are legally required to disclose such information in advertisements offline and, after years’ worth of reprimands from the FDA for not doing so, they’ve gotten the message, Findlay said. The way this message translates to the online world has yet to be seen.

Findlay tells us that a draft of regulations or guidelines for online marketing could come this year with a final ruling within two years. These regulations will most likely clarify the full disclosure of risks/benefits issue, he said.

“One should never make the mistake of underestimating the capacity, the resources and the willingness of companies to really aggressively marketing their products and to walk a thin line obeying the regulations,” he says. “They’ll go right up to the point where they don’t want to cross into illegality — but they come close.”

office de tourisme de fontainbleau by L'agence Medianet

victimized by Unfair and Deceptive Predatory Mortgage Lending practices. If you believe that you may be a victim of predatory lending, our Comprehensive Investiga internet marketing course

09
lutego

 tracking personal finances

Are You Tracking Your Budget, Cash Flow, and Net Worth? [Dumb Little Man] “Tracking your net worth on some sort of regular schedule is a must for anyone serious about decreasing debt and increasing wealth.”

11 moves to supercharge your finances [Smart Spending] “11 steps you can take to easily improve your finances in the coming year.”

The Damage of Card Rewards [NY Times] “It’s possible that the poor pay subsidies to finance the rewards of the affluent.”

How Poker Can Make You a Better Investor “Learn to avoid emotional traps by playing a little Texas hold ’em.”

The Future of Plastic: 5 Credit Trends for 2010 [Smart Money] “If 2009 was the year of hammering out credit-card reform, 2010 will be the year consumers feel the effects of those changes.”

— FREE MONEY FINANCE

Comments

Subscribe to comments for this post OR Subscribe to comments for all ReadWriteWeb posts

  1. @rww there's a new UK personal finance site in beta called @MoneyDashboard http://www.moneydashboard.com/

     Posted by: Steven Renwick |
    January 7, 2010 12:22 PM

  2. Also don't forget freeagent http://www.freeagentcentral.com/ - it's great for the self employed in the UK, with built in invoice tracking and self-assessment.

    Posted by: Andy B |
    January 7, 2010 2:21 PM

  3. I have used mint off and on. I love how the design and user interface, but I wish it would work with the bank that holds my checking account. Perhaps i'll try out some of your other suggestions. Thanks for the info!

    JG
    loanpointusa

    Posted by: Joe |
    January 7, 2010 2:35 PM

  4. I've been very happy with Xpenser. I can setup a budget and record expenses with email and sms (it also does twitter and im and a few other things). The main thing for me is ease of use so I stick with it, and this is the only one simple enough to stay with.

    Posted by: Paula |
    January 7, 2010 3:33 PM

  5. For those looking for a more proactive approach to managing finances and budgeting (versus the reactive reporting approach supported by most tools), check out the Easy Envelope Budget Aid, built natively for Android and the mobile Web. It's based on the envelope budgeting approach of setting aside cash for particular expenses–in advance–and then spending out of those categories on a declining balance basis. Stop before you run out of your balance as opposed to find out after-thefact that you overspent.

    EEBA lets you check your envelope balances and record transactions at point of sale allowing you to carry your virtual “envelopes” with you.

    We're in open Beta right now, website at www.eebacanhelp.com

    Posted by: Chi-Ming @ EEBA |
    January 7, 2010 5:27 PM

  6. Where is Mint's mobile site? I've never seen it.

     Posted by: Sivan |
    January 7, 2010 6:08 PM

  7. There is also Serbian money management web application Slamarica . It's oriented not just for Serbia, but for all Adriatic region. There's more info on Digg http://digg.com/business_finance/Serbian_No_1_money_management_home_finance_web_application

     Posted by: Nemanja Djordjevic |
    January 9, 2010 1:04 AM

  8. Thanks for this article. I'm looking forward to the rest. I find it interesting that http://moneycenter.yodlee.com doesn't show up more often in personal finance software reviews. It's free as well, and is quite feature rich. Part of the problem is Yodlee doesn't do that much to market the consumer side. (For good reason, they give it away. :-)

     Posted by: Philip Eoute |
    January 9, 2010 9:54 PM

  9. @Chi-Ming thanks for telling us about EEBA. I'm definitely trying that out!

     Posted by: Philip Eoute |
    January 9, 2010 9:55 PM

  10. @Philip, you're welcome. We're iterating quickly, so let us know what you think!

    Posted by: Chi-Ming @ EEBA |
    January 9, 2010 11:01 PM

  11. I just love Mint… simple and easy to use… user friendly.. what can I say! Thumb up!

    Posted by: RichDadWisdom |
    January 10, 2010 6:46 AM

  12. But with any of the above: (1) can you manually add accounts not on their automated list; (2) multiple currency feature; (3) mobile/iPhone app?

    I've tried Mint and Wesabe. Mint is US-only. Wesabe has dreadful import (all tags/categories are lost) and doesn't believe in account reconciliation (”Why would want that feature?” was their reply; perhaps b/c it's the oldest accounting feature in the book and I don't trust a bank's statement.)

    I'm with MoneyWell (which uses envelope accounting), and is serving me well enough. But everyone's been waiting well over a year for a promised iPhone app.

    I would pay handsomely for any online financial programme that satisfied all 3 feature requests above.

    Posted by: Mr Ulster |
    January 11, 2010 6:22 AM

  13. In the uk theres http://www.inniaccounts.co.uk, but it's more for contractors

    Posted by: Toby |
    January 11, 2010 11:47 PM

  14. I started using Mint but quickly realized that its sponsors and partners, the big banks, don't want you to use cash. Most of these “free” sites to manage your money encourage one thing - card use. Whether it's credit cards or debit cards, they make using and tracking them easy, and using and tracking cash difficult. This is because the banks all make money on card transactions, whether they are debit or credit based. They make no money on cash transactions. One of the best ways to save money and control spending is by using cash, and none of these services encourage that, by their design.

    Posted by: B |
    January 13, 2010 11:54 AM

  15. Interesting article - what is the revenue model for sites like Mint, Kublax, MoneyStrands if the resource is free?

    Posted by: Ciaran O'Reilly |
    January 14, 2010 7:05 AM

  16. Mvelopes also offers online personal finance management. It isn't free but I like the envelope based budgeting which forces you to cut down on spending. It also offers mobile access so you can track your spending while you're out shopping.

    Posted by: Valerie @ Finance Software Store |
    January 14, 2010 5:28 PM

  17. I wonder how Cloud computing will influence online financial transactions. I am waiting to see what security issues evolve first.

    Posted by: Stop Home Foreclosure |
    January 18, 2010 5:53 PM

  18. Does anyone have any recommendations for Australia?

    Posted by: Marksin |
    January 21, 2010 2:07 PM

  19. How do users of these web-based financial programs feel about having their financial data available to these companies and the problematic privacy issues?

    Posted by: Jeff |
    January 23, 2010 3:38 PM

  20. Yes, but does Mint allow you to export all your data (including tags/categories) so that you could port it into another program? As far as I can tell, it doesn't. I have several years of data built up using Quicken for Mac. This represents not only a lot of work on my part, but an important resource for understanding my spending patterns (not to mention for calculating capital gains/losses on stock transactions come tax time). I've gotten sick of Quicken's sucky user interface (and the fact that it doesn't run natively on an Intel/Leopard mac) and I'm going to switch either to iBank or Moneywell (haven't decided yet). These are both desktop programs. iBank already has an iPhone app that synchronizes with the desktop version, and Moneywell is building one. Importing all of my old data from Quicken into either of these programs will be a piece of cake, as will exporting from these programs should I change my mind later. They also talk with my bank, just as Mint does. With my data synchronized to my iPod touch, I'll have continuous access to it, all without losing control over it. The problem with Mint is that once you start spending time customizing your data, adding tags, etc, you can't leave the Mint interface without losing your work. I'm not going to use any platform that attempts to hold me hostage like that.

    Posted by: Sarah |
    January 24, 2010 11:33 AM

  21. In the UK we've been developing the new one on lovemoney.com - be good to know what you think of that too. https://www.lovemoney.com/onlinebanking/

     Posted by: emma davies |
    January 29, 2010 3:31 AM

  22. buy mutual funds, buy mutual funds, buy mutual funds, buy mutual funds, internet marketing, yahoo, google, Online advertising, http://www.prlog.org/10512637-franchisesforsalecom-launch-heralds-the-next-wave-in-franchisee-lead-generation.html, http://www.prlog.org/10512639-restaurant-franchise-opportunities-providing-new-job-opportunities.html, http://www.emailwire.com/release/30658-New-Lead-Site-FranchisesforsaleCom-Goes-Live.html, http://www.emailwire.com/release/31568-New-Franchise-Opportunities-for-2010-Online-Tools-and-Resources-for-Buying-a-Franchise.html, http://www.ideamarketers.com/?New_Franchise_Opportunities_for_2010_%E2%80%93_Online_Tools_and_Resources_for_Buying_a_&articleid=883071, http://www.earthtimes.org/articles/show/new-franchise-opportunities-for-2010,1100822.shtml, http://www.newsalbum.com/Read/473435-New-Franchise-Opportunities-with-Successful-Franchise-Companies-Putting-People-Back-to-Work/, http://www.transworldnews.com/NewsStory.aspx?id=164465&cat=9, http://www.zimbio.com/Housing+Bubble+News/articles/7/Dr+Robert+S+Shumake, http://mortgagefraudreportmichigan.blogspot.com/2009/12/robert-shumake-fraud-report-tax.html, http://personals.szczecin.pl/index.php?topic=2.0, http://tweetmeme.com/story/339636355/surface-encounters-in-wixom-going-green-with-marble-granite-countertop-production, http://finance.bnet.com/bnet/?GUID=11076222&Page=MediaViewer&ChannelID=6526, http://www.ideamarketers.com/?Surface_Encounters_Ohio,_LLC_Celebrates_100_Years_of_Experience_with_Columbus_S&articleid=880865, http://viralvideochart.unrulymedia.com/youtube/surface_encounters_macomb_mi__counter_tops?id=VGJx3FcNE50, http://www.veoh.com/browse/morelike/v19614992esMzfMCZ#, http://deals.yahoo.com/local-store-coupons/mer-surface-encounters–dept-home-garden, http://www.bignews.biz/?id=835928&keys=Shopping-counter-surface-Granite, http://www.businessweek.com/bios/Bill_Bartmann.htm, http://www.businessweek.com/archives/1998/b3603113.arc.htm, http://www.businessweek.com/smallbiz/content/apr2009/sb20090421_494148.htm?chan=smallbiz_smallbiz%20index%20page_top%20small%20business%20stories sell my home fast

    Good <b>News</b>! G7 Nations Announce They Will Cancel Haiti's Debt <b>…</b>

    I am so pleased this is finally happening. Haiti has been burdened by its national debt for a long time and this will help speed their recovery from the massive earthquake: The world's leading industrialised nations have pledged to …

    Red Eye Celebrates Third Year By Topping CNN Prime Time Last Week <b>…</b>

    MSNBC's David Shuster became a fan of Fox <b>News</b>' late-night comedy/<b>news</b> hybrid Red Eye just in time for its three-year anniversary. And it's coming at a time when the 3amET show is seeing big ratings in the A25-54 demographic - even …

    SourceForge.net: Some good <b>news</b>: SourceForge removes blanket blocking

    If this topic is <b>news</b> to you, please read the statement we made explaining what we did last month and why. In brief, we blocked all users from certain countries from downloading software using the site. Our action provoked a strong, …





marzec 2010
P W Ś C P S N
« lutego    
1234567
891011121314
15161718192021
22232425262728
293031  

Ostatnie komentarze

    Brak komentarzy

Linki

Farma plakietek

  • Firefox 2
  • CSSEdit 2
  • Textmate
  • Powered by Redoable 1.0